The House Ways & Means Committee on May 21 unanimously advanced the Provider Reimbursement Stability Act of 2026, which is endorsed by multiple radiology societies.
In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections.
Whether MOC should be mandatory for all is often debated among providers, but new findings indicate that opting not to participate may affect patient care.
Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders.
The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025.
The agencies are working together to produce Ra-226 from legacy radiological waste stored at National Institute of Standards and Technology facilities.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
The House Ways & Means Committee on May 21 unanimously advanced the Provider Reimbursement Stability Act of 2026, which is endorsed by multiple radiology societies.
